🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Purpose of this trial is: * to determine complete response rate (CRR) ...
Status
Completed
Location
1st Dept. of Medicine, Cologne University Hospital
Start Date
2012-10
Trial ID
NCT01569204
The purpose of this study is to find out if there is a benefit of adding He...
Status
Completed
Location
Hays Medical Center
Start Date
2009-07
Trial ID
NCT00944047
Treatments Being Tested
This was a Phase III, randomized, double-blind, placebo-controlled, multice...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00282347
The purpose of the study is to determine the capability of a radiolabeled a...
Status
Completed
Location
University of Tennessee Medical Center
Start Date
2008-11
Trial ID
NCT01409148
Treatments Being Tested
Introduction: Non-infectious uveitis (NIUs) include a heterogeneous group o...
Status
Unknown
Location
Complejo Hospitalario Universitario A Coruña
Start Date
2022-01-12
Trial ID
NCT04798755
Treatments Being Tested
Phase 1a/1b does-escalation study of cabiralizumab alone and with nivolumab...
Status
Completed
Location
Scottsdale Healthcare Hospitals DBA Honor Health
Start Date
2015-09-08
Trial ID
NCT02526017
Treatments Being Tested
High-grade gliomas (HGGs) are among the most aggressive and treatment-resis...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2026-03-27
Trial ID
NCT07210632
Treatments Being Tested
This is an open-label, single-arm, single-cohort, prospective clinical stud...
Status
Not Yet Recruiting
Location
Departmeng of Urology, Peking University First Hospita
Start Date
2026-08-01
Trial ID
NCT07720921
Treatments Being Tested
This phase II trial studies the side effects and how well nivolumab and ibr...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2019-02-15
Trial ID
NCT03770416
The purpose of this study is to determine that panitumumab will have clinic...
Status
Completed
Location
Multiple Locations
Start Date
2004-03
Trial ID
NCT00083616
Treatments Being Tested